| INTRODUCTION
Peripartum cardiomyopathy (PPCM) is a dilated cardiomyopathy marked by systolic dysfunction occurring at the end of pregnancy or, more commonly, in the early postpartum period. 1, 2 Globally, incidence appears to be highest in Nigeria (up to 1 in 100 live births) 3 and Haiti
(1 in 300 live births). 4 In the United States, the incidence of PPCM is rising 5 and is approximately 4-fold higher in black women (1 in 1000-1500 live births) than in Caucasian women (1 in 4000 live births). 2, 6 Other risk factors include older maternal age, multiple gestation, and preeclampsia. 7, 8 The etiology of PPCM remains unclear; proposed mechanisms have included angiogenic factor imbalance, abnormal prolactin cleavage, inflammation, selenium deficiency, and genetic susceptibility. [9] [10] [11] [12] [13] [14] More than half of women recover left ventricular (LV) function after PPCM, but a significant proportion is left with chronic heart failure, and some women require ventricular assist device (VAD) implantation or cardiac transplantation. In a recent North American series of 100 women, the Investigations of Pregnancy-Associated Cardiomyopathy (IPAC) study, 72% of women experienced recovery in LV ejection fraction (LVEF) to >50% by 12 months. 15 Predictors of persistent LV dysfunction included LVEF <30% or LV end-diastolic diameter > 6 cm at diagnosis, black race, and late presentation. 15 Elevation in troponin, B-type natriuretic peptide, and soluble fms-like tyrosine kinase-1 (sFlt-1) may also portend adverse cardiac remodeling and outcomes. [16] [17] [18] There is limited and conflicting data on ECG abnormalities and their significance in women with PPCM. In a Nigerian series of ECGs for 54 cases of PPCM and 77 postpartum women without PPCM, women with PPCM had faster heart rate, longer QRS and QTc intervals, and a higher frequency of ST-T-wave abnormalities than controls. 19 Of note, the authors did not examine the prognostic significance of ECG findings in this cohort. In a series of 78 South African women, 59% had T-wave abnormalities, 12% had a bundle branch block (BBB), 10% had left atrial abnormality, and 6%
had ST-segment changes on baseline ECG. 20 Follow-up was available on only 56% of this cohort, but among women with follow-up, T-wave inversions and ST depressions on the presenting ECG were associated with lower LVEF at 6 months. 20 In a series of 77 women in Beijing with PPCM, neither QRS nor QTc interval nor the frequency of ST depressions differed between women who did and did not recover LV function. 17 As the phenotypic presentation of PPCM differs across continents, 21 Student t tests and Fisher exact tests were used to compare continuous and categorical variables between groups, respectively. The
Kaplan-Meier log-rank analysis was used to estimate event-free survival, which was defined as survival free from death, mechanical circulatory support, and/or cardiac transplantation. Event-free survival was compared by characteristics of the ECG at entry, including LAA, LVH, ST segment depression, and a "normal" ECG by the exact log-rank test. In addition, the LVEF at 6 and 12 months postpartum was compared by ECG characteristics at entry.
| RESULTS
Of the 100 women in the IPAC cohort, 88 had available baseline
ECGs. Demographic and clinical characteristics of these women are summarized in Table 1 . Mean age was 30 ± 6 years, and 15 (17%)
presented with multiple gestation. Diabetes was present in 10 (11%) and hypertension in 38 (43%). At baseline, mean systolic and diastolic blood pressures were 111 ± 17 mm Hg and 70 ± 13 mm Hg, respectively. LVEF at entry was 34% ± 10% and LV end-diastolic dimension was 5.6 ± 0.7 cm. 15 By 6 months, LVEF had increased to 51% ± 11%, and by 12 months to 53 ± 11%. Women with an "abnormal ECG" at study enrollment (defined as presence of BBB, ventricular hypertrophy, atrial abnormality, and/or ST-segment deviation) were more likely to receive inotropes and had a larger LV end-diastolic dimension (LVEDD) on baseline echocardiogram (58 vs 54 mm, P = 0.002). Six women experienced nine major events: four deaths, four LVAD implantations, and one cardiac transplantation. Of women who required an LVAD, two died and one later underwent cardiac transplantation.
| Electrocardiographic findings
Findings of 12-lead ECGs at study enrollment are summarized in Table 2 . One woman was in atrial fibrillation, and all other subjects were in sinus rhythm; 45 (51%) had a normal sinus rhythm, 37 (42%)
showed sinus tachycardia, and 5 (6%) showed sinus bradycardia. Ventricular ectopic beats were observed in 3 subjects. QRS axis was normal in 74 (84%). There was no first-, second-, or third-degree atrioventricular block. Two subjects had a QRS duration >120 ms; one met criteria for left BBB, and the other right BBB. LAA was observed in 15 (17%), right atrial abnormality in 5 (6%), and LVH in 8 (9%) ECGs.
ST-segment depression was seen in 15 (17%) of women, and STsegment elevation was seen in 6 (7%). T-wave abnormalities were common, with flattening seen in 62 (71%) and inversions in 56 (64%).
A "normal" ECG, defined as absence of atrial abnormality, ventricular hypertrophy, ST-segment deviation, or BBB, was present in 43 (49%) of women. Tables 3 and 4 show the trajectory of LV function for women with and without various ECG and echocardiographic findings. As reported previously, 15 heart rate at enrollment was not correlated with LV recovery (P = 0.40 at 6 months and P = 0.26 at 12 months).
| Prediction of left ventricular recovery and event-free survival
LAA by ECG was specific (96%) but not sensitive (38%) for left atrial enlargement by echocardiogram. The presence of LAA on ECG was associated with lower LVEF at 6 months (44% vs 52%, P = 0.02) and 12 months (46% vs 54%, P = 0.03); these findings are almost identical to those comparing women with and without left atrial enlargement by echocardiogram (LVEF 46% vs 54% at 6 months (P = 0.003), and 47% vs 56% at 12 months (P = 0.001). As shown in Figure 1A , the presence of LAA by ECG additionally predicted decreased event-free survival at 1 year (76% vs 97%, P = 0.008).
LVH was evident by ECG criteria in eight women (9%) and was associated with a lower LVEF at entry (27% vs 35%, P = 0.03), but not at 6 months (45% vs 51%, P = 0.10) or 12 months (52% vs 53%, The presence of a "normal" ECG predicted a significantly higher LVEF at 6 months (53% vs 48%, P = 0.02), which was no longer significant at 12 months (55% vs 50%, P = 0.06). However, a normal ECG was associated with recovery to an LVEF ≥50% by 12 months (84% vs 49%, P = 0.001). Event-free survival at 1 year was significantly better (100% vs 85%, P = 0.013, Figure 1B) , as no events occurred in women with a normal ECG at entry. In our cohort, the majority of ECGs at study enrollment revealed sinus rhythm, a normal QRS axis, and normal intervals. LAA was seen in 17% of women and predicted both decreased recovery of LV function and decreased event-free survival. This finding is similar to that reported in a study of 468 patients with heart failure after non-STelevation myocardial infarction, in which electrocardiographic LAA was associated with higher risk of recurrent heart failure and mortality. 24 As noted, LAA by ECG was only 38% sensitive for left atrial enlargement as assessed by echocardiography. Prior work has suggested modest sensitivity of electrocardiographic LAA for left atrial enlargement measured by echocardiogram, with estimates ranging from 30%-75% when using terminal negative P-wave duration in V 1 > 40 ms. 25, 26 It is unclear from the available data whether electrical LAA is associated with adverse events because it indicates more severe left atrial enlargement or whether it is associated with adverse clinical events independent of left atrial size.
Importantly, a "normal" ECG was seen in 49% of women in our FIGURE 1 (A) Survival free from mechanical circulatory support, cardiac transplantation, and/or death for women with and without left atrial abnormality (LAA) on electrocardiogram (ECG) at study enrollment. (B) Survival free from mechanical circulatory support, cardiac transplantation, and/or death for women with a "normal" ECG (no atrial abnormality, ventricular hypertrophy, ST-segment deviation, or bundle branch block) or "abnormal" ECG at study enrollment
